| Entry |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Allantoin (JAN/USP) | ||||||||||
| Formula | C4H6N4O3 | ||||||||||
| Exact mass | 158.044 | ||||||||||
| Mol weight | 158.1154 | ||||||||||
| Structure |  | ||||||||||
| Simcomp | |||||||||||
| Remark |
| ||||||||||
| Efficacy | Anti-inflammatory, Vulnerary (topical) | ||||||||||
| Brite | Classification of Japanese OTC drugs [BR:br08313] Agents for urogenital organs and anus 30 Hemorrhoid drugs for external use D00121 Allantoin (JAN/USP) Agents for integumentary system 55 Chilblain and chap remedies D00121 Allantoin (JAN/USP) 57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches) D00121 Allantoin (JAN/USP) Agents for ophthalmologic use 62 General eye drops D00121 Allantoin (JAN/USP) Risk category of Japanese OTC drugs [BR:br08312] Third-class OTC drugs Inorganic and organic chemicals Allantoin D00121 Allantoin (JAN/USP) | ||||||||||
| Other DBs |
| ||||||||||
| KCF data | ATOM 11 1 C1y C 21.9677 -15.6281 2 N1x N 22.4062 -14.3008 3 C5x C 20.5701 -15.6281 4 N1b N 22.7921 -16.7623 5 C5x C 21.2718 -13.4764 6 N1x N 20.1316 -14.3008 7 O5x O 19.7516 -16.7623 8 C5a C 24.1837 -16.7561 9 O5x O 21.2718 -12.0731 10 N1a N 25.0022 -17.7505 11 O5a O 24.7507 -15.4815 BOND 11 1 1 2 1 2 1 3 1 3 1 4 1 4 2 5 1 5 3 6 1 6 3 7 2 7 4 8 1 8 5 9 2 9 8 10 1 10 8 11 2 11 5 6 1 |